Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Michael

Showing results (671-680 of 705) with videos related to

Pageof 71
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2007
Inhibition of the T790M gatekeeper mutant of the epidermal growth factor receptor by EXEL-7647Steven B Gendreau, Richard Ventura, Paul Keast, et al.
Genome Announcements|December 9, 2017
Genome Sequences of 19 <i>Rhodococcus erythropolis</i> Cluster CA PhagesJ Alfred Bonilla, Sharon Isern, Ann M Findley, et al.
Nature|May 8, 2024
Discovery of potent small-molecule inhibitors of lipoprotein(a) formationNuria Diaz, Carlos Perez, Ana Maria Escribano, et al.
Science (New York, N.Y.)|May 21, 2011
Thermal structure and dynamics of Saturn's northern springtime disturbanceLeigh N Fletcher, Brigette E Hesman, Patrick G J Irwin, et al.
Bioorganic & Medicinal Chemistry Letters|October 13, 2005
Estrogen receptor beta selective ligands: discovery and SAR of novel heterocyclic ligandsRichard Chesworth, Matthew D Wessel, Lisa Heyden, et al.
Plos One|January 30, 2014
Leukotriene B4 levels in human atherosclerotic plaques and abdominal aortic aneurysmsPleunie van den Borne, Sander W van der Laan, Sandra M Bovens, et al.
Cancer Cell|November 12, 2015
Targeting the AAA ATPase p97 as an Approach to Treat Cancer through Disruption of Protein HomeostasisDaniel J Anderson, Ronan Le Moigne, Stevan Djakovic, et al.
Molecular Cancer Therapeutics|March 18, 2014
Characterization of the activity of the PI3K/mTOR inhibitor XL765 (SAR245409) in tumor models with diverse genetic alterations affecting the PI3K pathwayPeiwen Yu, A Douglas Laird, Xiangnan Du, et al.
Journal of Lipid Research|June 23, 2019
Rare <i>DEGS1</i> variant significantly alters de novo ceramide synthesis pathwayNicholas B Blackburn, Laura F Michael, Peter J Meikle, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 25, 2005
Anthrax lethal factor inhibitionW L Shoop, Y Xiong, J Wiltsie, et al.
Pageof 71

Showing results (671-680 of 705) with videos related to

Sort By:
Pageof 71
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2007
Inhibition of the T790M gatekeeper mutant of the epidermal growth factor receptor by EXEL-7647Steven B Gendreau, Richard Ventura, Paul Keast, et al.
Genome Announcements|December 9, 2017
Genome Sequences of 19 <i>Rhodococcus erythropolis</i> Cluster CA PhagesJ Alfred Bonilla, Sharon Isern, Ann M Findley, et al.
Nature|May 8, 2024
Discovery of potent small-molecule inhibitors of lipoprotein(a) formationNuria Diaz, Carlos Perez, Ana Maria Escribano, et al.
Science (New York, N.Y.)|May 21, 2011
Thermal structure and dynamics of Saturn's northern springtime disturbanceLeigh N Fletcher, Brigette E Hesman, Patrick G J Irwin, et al.
Bioorganic & Medicinal Chemistry Letters|October 13, 2005
Estrogen receptor beta selective ligands: discovery and SAR of novel heterocyclic ligandsRichard Chesworth, Matthew D Wessel, Lisa Heyden, et al.
Plos One|January 30, 2014
Leukotriene B4 levels in human atherosclerotic plaques and abdominal aortic aneurysmsPleunie van den Borne, Sander W van der Laan, Sandra M Bovens, et al.
Cancer Cell|November 12, 2015
Targeting the AAA ATPase p97 as an Approach to Treat Cancer through Disruption of Protein HomeostasisDaniel J Anderson, Ronan Le Moigne, Stevan Djakovic, et al.
Molecular Cancer Therapeutics|March 18, 2014
Characterization of the activity of the PI3K/mTOR inhibitor XL765 (SAR245409) in tumor models with diverse genetic alterations affecting the PI3K pathwayPeiwen Yu, A Douglas Laird, Xiangnan Du, et al.
Journal of Lipid Research|June 23, 2019
Rare <i>DEGS1</i> variant significantly alters de novo ceramide synthesis pathwayNicholas B Blackburn, Laura F Michael, Peter J Meikle, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 25, 2005
Anthrax lethal factor inhibitionW L Shoop, Y Xiong, J Wiltsie, et al.
Pageof 71